denovoMATRIX

denovoMATRIX is a leading company in the field of cell culture technology based in Dresden, Germany. The company offers innovative solutions to improve cell production in biotechnology and regenerative medicine. With a focus on providing tools that enhance the quality, quantity, and safety of cell production, denovoMATRIX supports its customers in standardizing cell culture conditions and developing customized biomaterials.

denovoMATRIX offers a range of products specifically designed for the cultivation and expansion of cells in chemically defined and serum-free environments. The main products include:

• myMATRIX MSC: A chemically defined cell adhesion environment for the expansion of mesenchymal stem cells (MSCs) in serum-free media.
• myMATRIX iPSC: A synthetic cell culture substrate for the long-term expansion of induced pluripotent stem cells (iPSCs).
• beadMATRIX: Microcarriers that facilitate the transition from laboratory to industrial standard cell production.
• isoMATRIX: A solution for isolating highly proliferative MSCs in serum- and xeno-free media.

Additionally, denovoMATRIX offers services such as the screenSERVICE, which helps researchers identify the ideal cell culture environment, as well as the development and production of extracellular matrix biomimetic coatings.

The mission of denovoMATRIX is to redefine cell culture in the life sciences by providing biologically relevant and chemically defined solutions that are ATMP/GRAS compliant. The company aims to preserve and enhance the identity and function of cells in industrial processes to enable the next generation of cell culture solutions.

denovoMATRIX is committed to sustainable practices in cell production. By developing chemically defined and animal-free materials, the company contributes to reducing reliance on animal components in cell culture. This not only promotes the consistency and safety of cell products but also supports more environmentally friendly manufacturing processes.

The company works closely with leading partners such as PBS Biotech to improve manufacturing processes for cell and gene therapies. These collaborations aim to develop efficient and scalable methods for the production of iPSCs and other cell types. By combining expertise in cell culture technology and process development, denovoMATRIX positions itself as an innovation leader in the industry.

With a strong commitment to research and development and a clear vision for the future of cell culture technology, denovoMATRIX remains an indispensable partner for scientists and companies worldwide seeking advanced solutions for cell production.

1. https://www.denovomatrix.com/
2. https://www.denovomatrix.com/de/
3. https://www.denovomatrix.com/legal-disclosure/
4. https://www.denovomatrix.com/news/pbs-biotech-and-denovomatrix-join-forces-to-boost-manufacturing-processes-for-cell-gene-therapies/
5. https://www.denovomatrix.com/products/isomatrix/